Zhenhe Suo

  • Researcher, professor; PhD
  • +47 22 78 24 35

Publications 2020

Zhao J, Li X, Liu L, Cao J, Goscinski MA, Fan H, Li H, Suo Z (2020)
Oncogenic Role of Guanylate Binding Protein 1 in Human Prostate Cancer
Front Oncol, 9, 1494
DOI 10.3389/fonc.2019.01494, PubMed 31998647

Publications 2019

Fan Z, Li L, Li X, Zhang M, Dou M, Zhao J, Cao J, Deng X, Zhang M, Li H, Suo Z (2019)
Anti-senescence role of heterozygous fumarate hydratase gene knockout in rat lung fibroblasts in vitro
Aging (Albany NY), 11 (2), 573-589
DOI 10.18632/aging.101761, PubMed 30668541

Han H, Du Y, Zhao W, Li S, Chen D, Zhang J, Liu J, Suo Z, Bian X, Xing B, Zhang Z (2019)
Author Correction: PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells
Nat Commun, 10 (1), 2259
DOI 10.1038/s41467-019-10052-z, PubMed 31113949

Li X, Yang H, Wang J, Li X, Fan Z, Zhao J, Liu L, Zhang M, Goscinski MA, Wang J, Xu R, Fan H, Li H, Suo Z (2019)
High level of lncRNA H19 expression is associated with shorter survival in esophageal squamous cell cancer patients
Pathol Res Pract, 215 (11), 152638
DOI 10.1016/j.prp.2019.152638, PubMed 31551175

Liu L, Cao J, Zhao J, Li X, Suo Z, Li H (2019)
PDHA1 Gene Knockout In Human Esophageal Squamous Cancer Cells Resulted In Greater Warburg Effect And Aggressive Features In Vitro And In Vivo
Onco Targets Ther, 12, 9899-9913
DOI 10.2147/OTT.S226851, PubMed 31819487

Wang Z, Kang W, You Y, Pang J, Ren H, Suo Z, Liu H, Zheng Y (2019)
USP7: Novel Drug Target in Cancer Therapy
Front Pharmacol, 10, 427
DOI 10.3389/fphar.2019.00427, PubMed 31114498

Zhou W, Ma L, Ding L, Guo Q, He Z, Yang J, Qiao H, Li L, Yang J, Yu S, Zhao L, Wang S, Liu HM, Suo Z, Zhao W (2019)
Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M Interaction
J Med Chem, 62 (11), 5382-5403
DOI 10.1021/acs.jmedchem.9b00003, PubMed 31157974

Zhou W, Ma L, Yang J, Qiao H, Li L, Guo Q, Ma J, Zhao L, Wang J, Jiang G, Wan X, Adam Goscinski M, Ding L, Zheng Y, Li W, Liu H, Suo Z, Zhao W (2019)
Potent and specific MTH1 inhibitors targeting gastric cancer
Cell Death Dis, 10 (6), 434
DOI 10.1038/s41419-019-1665-3, PubMed 31164636

Publications 2018

Dou M, Zhou X, Fan Z, Ding X, Li L, Wang S, Xue W, Wang H, Suo Z, Deng X (2018)
Clinical Significance of Retinoic Acid Receptor Beta Promoter Methylation in Prostate Cancer: A Meta-Analysis
Cell Physiol Biochem, 45 (6), 2497-2505
DOI 10.1159/000488268, PubMed 29554659

Fan Z, Xue W, Li L, Zhang C, Lu J, Zhai Y, Suo Z, Zhao J (2018)
Identification of an early diagnostic biomarker of lung adenocarcinoma based on co-expression similarity and construction of a diagnostic model
J Transl Med, 16 (1), 205
DOI 10.1186/s12967-018-1577-5, PubMed 30029648

Karlsen H, Dong T, Suo Z (2018)
A Diaper Pad for Diaper-Based Urine Collection and Colorimetric Screening of Urinary Biomarkers
Ann Biomed Eng, 46 (5), 717-725
DOI 10.1007/s10439-018-1996-8, PubMed 29464459

Zhang M, Li X, Fan Z, Zhao J, Liu S, Zhang M, Li H, Goscinski MA, Fan H, Suo Z (2018)
High SRPX2 protein expression predicts unfavorable clinical outcome in patients with prostate cancer
Onco Targets Ther, 11, 3149-3157
DOI 10.2147/OTT.S158820, PubMed 29881288

Publications 2017

Li X, Grigalavicius M, Li Y, Li X, Zhong Y, Huang R, Yu D, Berge V, Goscinski MA, Kvalheim G, Nesland JM, Suo Z (2017)
MtDNA depletion influences the transition of CD44 subtypes in human prostate cancer DU145 cells
Tumour Biol, 39 (8), 1010428317713671
DOI 10.1177/1010428317713671, PubMed 28789597

Li X, Han G, Li X, Kan Q, Fan Z, Li Y, Ji Y, Zhao J, Zhang M, Grigalavicius M, Berge V, Goscinski MA, Nesland JM, Suo Z (2017)
Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells
Oncotarget, 8 (28), 46363-46380
DOI 10.18632/oncotarget.18199, PubMed 28624784

Li X, Lu J, Kan Q, Li X, Fan Q, Li Y, Huang R, Slipicevic A, Dong HP, Eide L, Wang J, Zhang H, Berge V, Goscinski MA, Kvalheim G, Nesland JM, Suo Z (2017)
Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells
Sci Rep, 7 (1), 5081
DOI 10.1038/s41598-017-05086-6, PubMed 28698547

Li X, Zhong Y, Lu J, Axcrona K, Eide L, Syljuåsen RG, Peng Q, Wang J, Zhang H, Goscinski MA, Kvalheim G, Nesland JM, Suo Z (2017)
Correction: MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features
Oncotarget, 8 (4), 7208-7213
DOI 10.18632/oncotarget.14800, PubMed 28179591

Li Y, Li X, Kan Q, Zhang M, Li X, Xu R, Wang J, Yu D, Goscinski MA, Wen JG, Nesland JM, Suo Z (2017)
Mitochondrial pyruvate carrier function is negatively linked to Warburg phenotype in vitro and malignant features in esophageal squamous cell carcinomas
Oncotarget, 8 (1), 1058-1073
DOI 10.18632/oncotarget.13717, PubMed 27911865

Yang J, Zhang R, Shi C, Mao C, Yang Z, Suo Z, Torp R, Xu Y (2017)
AQP4 Association with Amyloid Deposition and Astrocyte Pathology in the Tg-ArcSwe Mouse Model of Alzheimer's Disease
J Alzheimers Dis, 57 (1), 157-169
DOI 10.3233/JAD-160957, PubMed 28222512

Zhong Y, Li X, Ji Y, Li X, Li Y, Yu D, Yuan Y, Liu J, Li H, Zhang M, Ji Z, Fan D, Wen J, Goscinski MA, Yuan L, Hao B, Nesland JM, Suo Z (2017)
Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers
Oncotarget, 8 (8), 13344-13356
DOI 10.18632/oncotarget.14527, PubMed 28076853

Publications 2016

Hasvold G, Lund-Andersen C, Lando M, Patzke S, Hauge S, Suo Z, Lyng H, Syljuåsen RG (2016)
Hypoxia-induced alterations of G2 checkpoint regulators
Mol Oncol, 10 (5), 764-73
DOI 10.1016/j.molonc.2015.12.015, PubMed 26791779

Ji Y, Li X, Li Y, Zhong Y, Cao J, Xu R, Wang J, Zhou F, Li X, Yu D, Wen JG, Goscinski MA, Zhang M, Nesland JM, Suo Z (2016)
Aldehyde Dehydrogenase-1 Expression Predicts Unfavorable Outcomes in Patients with Esophageal Squamous Cell Carcinoma
Anticancer Res, 36 (1), 343-9
PubMed 26722063

Li X, Ji Y, Han G, Li X, Fan Z, Li Y, Zhong Y, Cao J, Zhao J, Zhang M, Wen J, Goscinski MA, Nesland JM, Suo Z (2016)
MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer
BMC Cancer, 16 (1), 894
DOI 10.1186/s12885-016-2941-6, PubMed 27852261

Li X, Li Y, Han G, Li X, Ji Y, Fan Z, Zhong Y, Cao J, Zhao J, Mariusz G, Zhang M, Wen J, Nesland JM, Suo Z (2016)
Establishment of mitochondrial pyruvate carrier 1 (MPC1) gene knockout mice with preliminary gene function analyses
Oncotarget, 7 (48), 79981-79994
DOI 10.18632/oncotarget.13210, PubMed 27835892

Li X, Zhong Y, Lu J, Axcrona K, Eide L, Syljuåsen RG, Peng Q, Wang J, Zhang H, Goscinski MA, Kvalheim G, Nesland JM, Suo Z (2016)
MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features
Oncotarget, 7 (26), 40297-40313
DOI 10.18632/oncotarget.9610, PubMed 27248169

Li Y, Huang R, Li X, Li X, Yu D, Zhang M, Wen J, Goscinski MA, Trope CG, Nesland JM, Suo Z (2016)
Decreased expression of pyruvate dehydrogenase A1 predicts an unfavorable prognosis in ovarian carcinoma
Am J Cancer Res, 6 (9), 2076-2087
PubMed 27725912

Li Y, Li X, Li X, Zhong Y, Ji Y, Yu D, Zhang M, Wen JG, Zhang H, Goscinski MA, Nesland JM, Suo Z (2016)
PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence
Oncotarget, 7 (33), 53837-53852
DOI 10.18632/oncotarget.10782, PubMed 27462778

Yu D, Holm R, Goscinski MA, Trope CG, Nesland JM, Suo Z (2016)
Prognostic and clinicopathological significance of Cacna2d1 expression in epithelial ovarian cancers: a retrospective study
Am J Cancer Res, 6 (9), 2088-2097
PubMed 27725913

Yu D, Zhong Y, Li X, Li Y, Li X, Cao J, Fan Z, Fan H, Yuan L, Xu B, Yuan Y, Zhang H, Ji Z, Wen JG, Zhang M, Nesland JM, Suo Z (2016)
Generation of TALEN-mediated FH knockout rat model
Oncotarget, 7 (38), 61656-61669
DOI 10.18632/oncotarget.11429, PubMed 27556703

Publications 2015

Goscinski MA, Larsen SG, Giercksky KE, Nesland JM, Suo Z (2015)
PDGFR-α and CD117 Expression Pattern in Esophageal Carcinomas
Anticancer Res, 35 (7), 3793-9
PubMed 26124324

Goscinski MA, Xu R, Zhou F, Wang J, Yang H, Huang R, Li Y, Larsen SG, Giercksky KE, Nesland JM, Suo Z (2015)
Nuclear, cytoplasmic, and stromal expression of ZEB1 in squamous and small cell carcinoma of the esophagus
APMIS, 123 (12), 1040-7
DOI 10.1111/apm.12473, PubMed 26547370

Han H, Du Y, Zhao W, Li S, Chen D, Zhang J, Liu J, Suo Z, Bian X, Xing B, Zhang Z (2015)
PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells
Nat Commun, 6, 8271
DOI 10.1038/ncomms9271, PubMed 26420065

Huang R, Li X, Holm R, Trope CG, Nesland JM, Suo Z (2015)
The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: a retrospective study
BMC Cancer, 15, 502
DOI 10.1186/s12885-015-1513-5, PubMed 26148881

Huang R, Wang J, Zhong Y, Liu Y, Stokke T, Trope CG, Nesland JM, Suo Z (2015)
Mitochondrial DNA Deficiency in Ovarian Cancer Cells and Cancer Stem Cell-like Properties
Anticancer Res, 35 (7), 3743-53
PubMed 26124317

Li X, Huang R, Li RH, Trope CG, Nesland JM, Suo Z (2015)
Expression of zinc finger E-box-binding homeobox factor 1 in epithelial ovarian cancer: A clinicopathological analysis of 238 patients
Mol Clin Oncol, 4 (1), 18-22
DOI 10.3892/mco.2015.662, PubMed 26870350

Li Y, Li X, Fan H, Li X, Zhong Y, Cao J, Yu D, Zhang M, Wen JG, Geng L, Suo Z (2015)
Age-dependent sex hormone-binding globulin expression in male rat
Ultrastruct Pathol, 39 (2), 121-30
DOI 10.3109/01913123.2015.1009222, PubMed 25879298

Sidaly R, Landin MA, Suo Z, Snead ML, Lyngstadaas SP, Reseland JE (2015)
Hypoxia increases the expression of enamel genes and cytokines in an ameloblast-derived cell line
Eur J Oral Sci, 123 (5), 335-340
DOI 10.1111/eos.12201, PubMed 26193448

Xu B, Yuan L, Gao Q, Yuan P, Zhao P, Yuan H, Fan H, Li T, Qin P, Han L, Fang W, Suo Z (2015)
Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer
Oncotarget, 6 (24), 20592-603
DOI 10.18632/oncotarget.4112, PubMed 26008981

Yu D, Zhong Y, Li X, Li Y, Li X, Cao J, Fan H, Yuan Y, Ji Z, Qiao B, Wen JG, Zhang M, Kvalheim G, Nesland JM, Suo Z (2015)
ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells in vitro
Oncotarget, 6 (40), 42687-703
DOI 10.18632/oncotarget.5883, PubMed 26528857

Zhong Y, Huang R, Li X, Xu R, Zhou F, Wang J, Fan H, Goscinski M, Zhang M, Wen JG, Nesland JM, Suo Z (2015)
Decreased Expression of PDHE1α Predicts Worse Clinical Outcome in Esophageal Squamous Cell Carcinoma
Anticancer Res, 35 (10), 5533-8
PubMed 26408721

Zhong Y, Li X, Yu D, Li X, Li Y, Long Y, Yuan Y, Ji Z, Zhang M, Wen JG, Nesland JM, Suo Z (2015)
Application of mitochondrial pyruvate carrier blocker UK5099 creates metabolic reprogram and greater stem-like properties in LnCap prostate cancer cells in vitro
Oncotarget, 6 (35), 37758-69
DOI 10.18632/oncotarget.5386, PubMed 26413751

Publications 2014

Huang R, Wu D, Yuan Y, Li X, Holm R, Trope CG, Nesland JM, Suo Z (2014)
CD117 expression in fibroblasts-like stromal cells indicates unfavorable clinical outcomes in ovarian carcinoma patients
PLoS One, 9 (11), e112209
DOI 10.1371/journal.pone.0112209, PubMed 25380303

Wu Q, Shi H, Holm R, Li X, Trope C, Nesland JM, Suo Z (2014)
Aldehyde dehydrogenase-1 predicts favorable prognosis in patients with vulvar squamous cell carcinoma
Anticancer Res, 34 (2), 859-65
PubMed 24511023

Publications 2013

Fan H, Yuan Y, Wang J, Zhou F, Zhang M, Giercksky KE, Nesland JM, Suo Z (2013)
CD117 expression in operable oesophageal squamous cell carcinomas predicts worse clinical outcome
Histopathology, 62 (7), 1028-37
DOI 10.1111/his.12111, PubMed 23570416

Han LP, Li MM, Zhang XX, Geng LN, Suo ZH (2013)
[Influence of EphA2 siRNA transfection on the biological behavior of human ovarian carcinoma cell]
Sichuan Da Xue Xue Bao Yi Xue Ban, 44 (6), 877-81
PubMed 24490493

Huang R, Ma Y, Holm R, Trope CG, Nesland JM, Suo Z (2013)
Sex hormone-binding globulin (SHBG) expression in ovarian carcinomas and its clinicopathological associations
PLoS One, 8 (12), e83238
DOI 10.1371/journal.pone.0083238, PubMed 24386165

Liu J, Fan H, Ma Y, Liang D, Huang R, Wang J, Zhou F, Kan Q, Ming L, Li H, Giercksky KE, Nesland JM, Suo Z (2013)
Notch1 is a 5-fluorouracil resistant and poor survival marker in human esophagus squamous cell carcinomas
PLoS One, 8 (2), e56141
DOI 10.1371/journal.pone.0056141, PubMed 23409141

Liu Y, Sæter T, Vlatkovic L, Servoll E, Waaler G, Axcrona U, Giercksky KE, Nesland JM, Suo ZH, Axcrona K (2013)
Dendritic and lymphocytic cell infiltration in prostate carcinoma
Histol Histopathol, 28 (12), 1621-8
DOI 10.14670/HH-28.1621, PubMed 23729368

Liu Y, Wu X, Li X, Kvalheim G, Axcrona U, Axcrona K, Suo Z (2013)
Blocking mtDNA replication upregulates the expression of stemness-related genes in prostate cancer cell lines
Ultrastruct Pathol, 37 (4), 258-66
DOI 10.3109/01913123.2013.770112, PubMed 23634795

Ma Y, Liang D, Liu J, Wen JG, Servoll E, Waaler G, Sæter T, Axcrona K, Vlatkovic L, Axcrona U, Paus E, Yang Y, Zhang Z, Kvalheim G, Nesland JM, Suo Z (2013)
SHBG is an important factor in stemness induction of cells by DHT in vitro and associated with poor clinical features of prostate carcinomas
PLoS One, 8 (7), e70558 (Retracted)
DOI 10.1371/journal.pone.0070558, PubMed 23936228

Shahzidi S, Brech A, Sioud M, Li X, Suo Z, Nesland JM, Peng Q (2013)
Lamin A/C cleavage by caspase-6 activation is crucial for apoptotic induction by photodynamic therapy with hexaminolevulinate in human B-cell lymphoma cells
Cancer Lett, 339 (1), 25-32
DOI 10.1016/j.canlet.2013.07.026, PubMed 23916608

Wang P, Gao Q, Suo Z, Munthe E, Solberg S, Ma L, Wang M, Westerdaal NA, Kvalheim G, Gaudernack G (2013)
Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines
PLoS One, 8 (3), e57020 (Retracted)
DOI 10.1371/journal.pone.0057020, PubMed 23469181

Wang P, Suo Z, Wang M, Høifødt HK, Fodstad O, Gaudernack G, Kvalheim G (2013)
In vitro and in vivo properties of CD133 expressing cells from human lung cancer cell lines
Exp Hematol Oncol, 2 (1), 16
DOI 10.1186/2162-3619-2-16, PubMed 23738757

Wen JG, Li JS, Wang ZM, Huang CX, Shang XP, Su ZQ, Lu YT, Suo ZH, Wang Y, Qin GJ, Zhang WX, Heesakkers JP (2013)
The prevalence and risk factors of OAB in middle-aged and old people in China
Neurourol Urodyn, 33 (4), 387-91
DOI 10.1002/nau.22429, PubMed 23765684

Publications 2012

Liang D, Ma Y, Liu J, Trope CG, Holm R, Nesland JM, Suo Z (2012)
The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells
BMC Cancer, 12, 201
DOI 10.1186/1471-2407-12-201, PubMed 22642602

Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Giercksky KE, Nesland JM, Suo Z (2012)
Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines
Tumour Biol, 33 (4), 967-78
DOI 10.1007/s13277-012-0325-3, PubMed 22252524

Publications 2011

Bruheim S, Kristian A, Uenaka T, Suo Z, Tsuruoka A, Nesland JM, Fodstad Ø (2011)
Antitumour activity of oral E7080, a novel inhibitor of multiple tyrosine kinases, in human sarcoma xenografts
Int J Cancer, 129 (3), 742-50
DOI 10.1002/ijc.25922, PubMed 21225632

Han LP, Liu JF, Liu XR, Dong ZM, Suo ZH (2011)
[Expression and prognostic significance of EphA2 and EphrinA-1 in ovarian serous carcinomas]
Sichuan Da Xue Xue Bao Yi Xue Ban, 42 (2), 179-84
PubMed 21500549

Lü X, Deng Q, Li H, Suo Z (2011)
Altered characteristics of cancer stem/initiating cells in a breast cancer cell line treated with persistent 5-FU chemotherapy
Exp Ther Med, 2 (5), 821-826
DOI 10.3892/etm.2011.279, PubMed 22977582

Lü X, Xu K, Lü H, Yin Y, Ma C, Liu Y, Li H, Suo Z (2011)
CD44(+)/CD24(-) cells are transit progenitors and do not determine the molecular subtypes and clinical parameters in breast carcinomas
Ultrastruct Pathol, 35 (2), 72-8
DOI 10.3109/01913123.2010.544843, PubMed 21299347

Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Stokke T, Nesland JM, Suo Z (2011)
Prostate cancer cell lines under hypoxia exhibit greater stem-like properties
PLoS One, 6 (12), e29170 (Retracted)
DOI 10.1371/journal.pone.0029170, PubMed 22216200

Shi JH, Huitfeldt HS, Suo ZH, Line PD (2011)
Growth of hepatocellular carcinoma in the regenerating liver
Liver Transpl, 17 (7), 866-74
DOI 10.1002/lt.22325, PubMed 21542129

Wang Z, Nesland JM, Suo Z, Trope CG, Holm R (2011)
The prognostic value of 14-3-3 isoforms in vulvar squamous cell carcinoma cases: 14-3-3β and ε are independent prognostic factors for these tumors
PLoS One, 6 (9), e24843
DOI 10.1371/journal.pone.0024843, PubMed 21935479

Publications 2010

Prasmickaite L, Engesaeter BØ, Skrbo N, Hellenes T, Kristian A, Oliver NK, Suo Z, Maelandsmo GM (2010)
Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma
PLoS One, 5 (5), e10731
DOI 10.1371/journal.pone.0010731, PubMed 20505780

Prasmickaite L, Skrbo N, Høifødt HK, Suo Z, Engebråten O, Gullestad HP, Aamdal S, Fodstad Ø, Maelandsmo GM (2010)
Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells
Pigment Cell Melanoma Res, 23 (3), 449-51
DOI 10.1111/j.1755-148X.2010.00690.x, PubMed 20236249

Wang Z, He W, Yang G, Wang J, Wang Z, Nesland JM, Holm R, Suo Z (2010)
Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma
BMC Cancer, 10, 352
DOI 10.1186/1471-2407-10-352, PubMed 20602752

Wang Z, Trope CG, Flørenes VA, Suo Z, Nesland JM, Holm R (2010)
Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes
BMC Cancer, 10, 233
DOI 10.1186/1471-2407-10-233, PubMed 20500813

Publications 2009

Chen X, Cao X, Dong W, Luo S, Suo Z, Jin Y (2009)
Expression of TIP30 tumor suppressor gene is down-regulated in human colorectal carcinoma
Dig Dis Sci, 55 (8), 2219-26
DOI 10.1007/s10620-009-0992-0, PubMed 19798571

Fan T, Jiang G, Suo Z, Liu H, Xu P, Ji Z, Zhang L, Yang G (2009)
Down-regulation of the apoptosis-inducing factor or Bcl-2 inhibitor of transcription by RNA interference can alleviate TAp63gamma-induced apoptosis in esophageal squamous carcinoma EC9706 cells
Int J Oncol, 35 (2), 359-67
DOI 10.3892/ijo_00000347, PubMed 19578750

Gao Q, Geng L, Kvalheim G, Gaudernack G, Suo Z (2009)
Identification of cancer stem-like side population cells in ovarian cancer cell line OVCAR-3
Ultrastruct Pathol, 33 (4), 175-81
DOI 10.1080/01913120903086072, PubMed 19728235

Goscinski MA, Larsen SG, Warloe T, Stoldt S, Nesland JM, Suo ZH, Giercksky KE (2009)
Adenocarcinomas on the rise--does it influence survival from oesophageal cancer?
Scand J Surg, 98 (4), 214-20
DOI 10.1177/145749690909800404, PubMed 20218417

He W, Wang Z, Wang Q, Fan Q, Shou C, Wang J, Giercksky KE, Nesland JM, Suo Z (2009)
Expression of HIWI in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis
BMC Cancer, 9, 426
DOI 10.1186/1471-2407-9-426, PubMed 19995427

Liu Y, Geng L, Suo Z (2009)
Differentiation effect of pyruvate and uridine on cultured U937-rho degrees cells
Ultrastruct Pathol, 33 (4), 160-4
DOI 10.1080/01913120902889187, PubMed 19728232

Lü X, Li H, Xu K, Nesland JM, Suo Z (2009)
MUC-1-/ESA+ progenitor cells in normal, benign and malignant human breast epithelial cells
Histol Histopathol, 24 (11), 1381-90
DOI 10.14670/HH-24.1381, PubMed 19760587

Lü XQ, Suo Z, Ma CL, Xu KJ, Liu YS, Li HX (2009)
[Quantity and distribution of CD44+/CD24- cells in breast cancer tissue and the cell lines]
Zhonghua Bing Li Xue Za Zhi, 38 (7), 441-4
PubMed 19781189

Wang Q, He W, Lu C, Wang Z, Wang J, Giercksky KE, Nesland JM, Suo Z (2009)
Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma
Anticancer Res, 29 (4), 1233-41
PubMed 19414369

Publications 2008

Goscinski MA, Suo Z, Flørenes VA, Vlatkovic L, Nesland JM, Giercksky KE (2008)
FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions
Ultrastruct Pathol, 32 (3), 89-96
DOI 10.1080/01913120802034934, PubMed 18570153

Goscinski MA, Suo ZH, Nesland JM, Chen WT, Zakrzewska M, Wang J, Zhang S, Flørenes VA, Giercksky KE (2008)
Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China
Oncology, 75 (1-2), 49-59
DOI 10.1159/000151741, PubMed 18787344

Goscinski MA, Suo ZH, Nesland JM, Flørenes VA, Giercksky KE (2008)
Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal squamous cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines
APMIS, 116 (9), 823-31
DOI 10.1111/j.1600-0463.2008.01029.x, PubMed 19024603

Holm R, de Putte GV, Suo Z, Lie AK, Kristensen GB (2008)
Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis
Int J Med Sci, 5 (3), 121-6
DOI 10.7150/ijms.5.121, PubMed 18566674

Wang Z, Tropè CG, Suo Z, Trøen G, Yang G, Nesland JM, Holm R (2008)
The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas
BMC Cancer, 8, 308
DOI 10.1186/1471-2407-8-308, PubMed 18950492

Zhang MZ, Qiao YH, Suo ZH (2008)
[Correlation of DPPIV expression with clinicopathological features and prognosis in epithelial ovarian carcinoma]
Zhonghua Zhong Liu Za Zhi, 30 (11), 848-52
PubMed 19173831

Publications 2007

Wang Q, Wang T, Wang Y, Wang W, Wang Y, Hu X, Shao S, Zhang J, Suo Z (2007)
VP-16 resistance in the NCI-H460 human lung cancer cell line is significantly associated with glucose-regulated protein78 (GRP78) induction
Anticancer Res, 27 (4B), 2359-64
PubMed 17695526

Wu Q, Lind GE, Aasheim HC, Micci F, Silins I, Tropé CG, Nesland JM, Lothe RA, Suo Z (2007)
The EPH receptor Bs (EPHBs) promoters are unmethylated in colon and ovarian cancers
Epigenetics, 2 (4), 237-43
DOI 10.4161/epi.2.4.5406, PubMed 18281782

Wu Q, Lothe RA, Ahlquist T, Silins I, Tropé CG, Micci F, Nesland JM, Suo Z, Lind GE (2007)
DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets
Mol Cancer, 6, 45
DOI 10.1186/1476-4598-6-45, PubMed 17623056

Zhang MZ, Qiao YH, Nesland JM, Trope C, Kennedy A, Chen WT, Suo ZH (2007)
Expression of seprase in effusions from patients with epithelial ovarian carcinoma
Chin Med J (Engl), 120 (8), 663-8
PubMed 17517181

Publications 2006

Aghmesheh M, Suo Z, Friedlander M, Nesland JM, Kaern J, Stewart M, Kconfab, Dorum A, Tucker KM, Buckley MF (2006)
Chromosome 2q24.2 is lost in sporadic but not in BRCA1-associated ovarian carcinomas
Pathology, 38 (2), 145-51
DOI 10.1080/00313020600561526, PubMed 16680901

Chen D, Kennedy A, Wang JY, Zeng W, Zhao Q, Pearl M, Zhang M, Suo Z, Nesland JM, Qiao Y, Ng AK, Hirashima N, Yamane T, Mori Y, Mitsumata M, Ghersi G, Chen WT (2006)
Activation of EDTA-resistant gelatinases in malignant human tumors
Cancer Res, 66 (20), 9977-85
DOI 10.1158/0008-5472.CAN-06-1499, PubMed 17047060

Han LP, Dong ZM, Qiao YH, Nesland JM, Suo ZH (2006)
[Expressions of estrogen receptor subtypes in epithelial ovarian carcinomas]
Sichuan Da Xue Xue Bao Yi Xue Ban, 37 (4), 606-10
PubMed 16909613

Ji Z, Yang G, Shahzidi S, Tkacz-Stachowska K, Suo Z, Nesland JM, Peng Q (2006)
Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy
Cancer Lett, 244 (2), 182-9
DOI 10.1016/j.canlet.2005.12.010, PubMed 16427735

Ji Z, Yang G, Vasovic V, Cunderlikova B, Suo Z, Nesland JM, Peng Q (2006)
Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines
J Photochem Photobiol B, 84 (3), 213-20
DOI 10.1016/j.jphotobiol.2006.03.006, PubMed 16709459

Wu Q, Suo Z, Kristensen GB, Baekelandt M, Nesland JM (2006)
The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma
Gynecol Oncol, 102 (1), 15-21
DOI 10.1016/j.ygyno.2005.11.034, PubMed 16499955

Publications 2005

Han L, Dong Z, Qiao Y, Kristensen GB, Holm R, Nesland JM, Suo Z (2005)
The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas
Gynecol Oncol, 99 (2), 278-86
DOI 10.1016/j.ygyno.2005.06.036, PubMed 16061279

Shi HR, Wu QH, Suo ZH, Nesland JM (2005)
[Correlation between methylation of 5'-CpG islands and inactivation of FHIT gene in cervical cancer]
Ai Zheng, 24 (1), 7-11
PubMed 15642192

Xu F, Zhong W, Li J, Shanshen Z, Cui J, Nesland JM, Suo Z (2005)
Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma
Anticancer Res, 25 (4), 2943-50
PubMed 16080548

Publications 2004

Davidson B, Suo Z, Nesland JM (2004)
Malignant mesothelioma
Ultrastruct Pathol, 28 (4), 179-80
DOI 10.1080/01913120490518051, PubMed 15693629

Suo Z, Daehli KU, Lindboe CF, Borgen E, Bassarova A, Nesland JM (2004)
Real-time PCR quantification of c-erbB-2 gene is an alternative for FISH in the clinical management of breast carcinoma patients
Int J Surg Pathol, 12 (4), 311-8
DOI 10.1177/106689690401200404, PubMed 15494857

Suo Z, Karbovo E, Trope CG, Metodiev K, Nesland JM (2004)
Papillary serous carcinoma of the ovary: an ultrastructural and immunohistochemical study
Ultrastruct Pathol, 28 (3), 141-7
DOI 10.1080/01913120490475716, PubMed 15471427

Wu D, Qiao Y, Kristensen GB, Li S, Troen G, Holm R, Nesland JM, Suo Z (2004)
Prognostic significance of dysadherin expression in cervical squamous cell carcinoma
Pathol Oncol Res, 10 (4), 212-8
DOI 10.1007/BF03033763, PubMed 15619642

Wu D, Suo Z, Kristensen GB, Li S, Troen G, Holm R, Nesland JM (2004)
Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma
Gynecol Oncol, 94 (2), 312-9
DOI 10.1016/j.ygyno.2004.05.019, PubMed 15297167

Wu Q, Suo Z, Risberg B, Karlsson MG, Villman K, Nesland JM (2004)
Expression of Ephb2 and Ephb4 in breast carcinoma
Pathol Oncol Res, 10 (1), 26-33
DOI 10.1007/BF02893405, PubMed 15029258

Publications 2003

Suo Z, Nesland JM (2003)
Electron microscopy in diagnosis of spindle cell tumors
Semin Diagn Pathol, 20 (1), 5-12
DOI 10.1053/sdia.2003.50006, PubMed 12693671

Wu Q, Shi H, Suo Z, Nesland JM (2003)
5'-CpG island methylation of the FHIT gene is associated with reduced protein expression and higher clinical stage in cervical carcinomas
Ultrastruct Pathol, 27 (6), 417-22
DOI 10.1080/01913120390250329, PubMed 14660280

Publications 2002

Suo Z, Nesland JM (2002)
Type 1 protein tyrosine kinases in breast carcinoma: a review
Ultrastruct Pathol, 26 (3), 125-35
DOI 10.1080/01913120290076784, PubMed 12184370

Suo Z, Nesland JM (2002)
Barrett's esophagus: intestinal metaplasia or phenotypic shift of undifferentiated elements in the stem cells
Ultrastruct Pathol, 26 (2), 53-4
DOI 10.1080/01913120252959218, PubMed 12036092

Suo Z, Risberg B, Kalsson MG, Willman K, Tierens A, Skovlund E, Nesland JM (2002)
EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival
J Pathol, 196 (1), 17-25
DOI 10.1002/path.1003, PubMed 11748637

Suo Z, Risberg B, Karlsson MG, Villman K, Skovlund E, Nesland JM (2002)
The expression of EGFR family ligands in breast carcinomas
Int J Surg Pathol, 10 (2), 91-9
DOI 10.1177/106689690201000202, PubMed 12075402

Yang H, Berner A, Mei Q, Giercksky KE, Warloe T, Yang G, Cui J, Suo Z, Zhang S, Nesland JM (2002)
Cytologic screening for esophageal cancer in a high-risk population in Anyang County, China
Acta Cytol, 46 (3), 445-52
DOI 10.1159/000326859, PubMed 12040635

Publications 2001

Suo Z (2001)
The epidermal growth factor receptor family and ligands in benign and malignant breast lesions
Department of Pathology, The Norwegian Radium Hospital and Institute for Cancer Research, Faculty of Medicine, University of Oslo, Oslo, 1 b. (flere pag.)
BIBSYS 011492147, ISBN 82-7633-169-6

Publications 1991

Suo ZH, Hu ZL (1991)
Case for the panel. Cytoplasmic structures in the cells of esophageal squamous cell carcinomas
Ultrastruct Pathol, 15 (3), 309-10
DOI 10.3109/01913129109021893, PubMed 1871903

Page visits: 5550